Rheomacrodex Side Effects

Generic name: dextran, low molecular weight

Note: This document provides detailed information about Rheomacrodex.

Applies to dextran, low molecular weight: intravenous solution Side Effects associated with dextran, low molecular weight. Some dosage forms listed on this page may not apply specifically to the brand name Rheomacrodex.

Applies to dextran, low molecular weight: intravenous solution.

Cardiovascular adverse events

• Frequency not reported: Tightness of the chest, hypotension
• Postmarketing reports: Cardiac arrest, shock^[Ref]

Dermatologic

• Frequency not reported: Mild urticarial reactions, generalized urticaria^[Ref]

Gastrointestinal

• Rare (less than 0.1%): Nausea, vomiting^[Ref]

Hypersensitivity

• Frequency not reported: Anaphylaxis
• Postmarketing reports: Dextran-induced anaphylactoid reaction (DIAR)^[Ref]

Local

• Frequency not reported: Febrile response, injection site infection, venous thrombosis or phlebitis extending from the site of injection, extravasation, hypervolemia^[Ref]

Other

• Frequency not reported: Fever^[Ref]

Respiratory

• Frequency not reported: Wheezing^[Ref]

See also:

Further information

Rheomacrodex side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer